The Use of Zoledronic Acid in Men on Androgen Deprivation Therapy for Prostate Cancer With Preexisting Osteoporosis.
Phase of Trial: Phase III
Latest Information Update: 28 Feb 2017
At a glance
- Drugs Zoledronic acid (Primary)
- Indications Male osteoporosis
- Focus Therapeutic Use
- Sponsors Novartis
- 15 Feb 2011 Actual end date (Mar 2007) added as reported by ClinicalTrials.gov.
- 29 Jul 2008 New trial record.